Targeting multiple mechanisms to treat amyotrophic lateral sclerosis

Optimization of treatments for amyotrophic lateral sclerosis (ALS) could require multiple cell types and pathogenic mechanisms to be targeted, according to new research published in Annals of Clinical and Translational Neurology. Brian Kaspar and ...
News Type: 

Share this page with friends using the buttons below:

Add new comment